Cite

HARVARD Citation

    Rusen, L. et al. (2018). Clinical experience with moroctocog alfa (AF‐CC) in younger paediatric patients with severe haemophilia A: Two open‐label studies. Haemophilia. 24 (4), pp. 604-610. [Online]. 
  
Back to record